Godfrey Quoted in POLITICO Pro on FDA Guidance for CBD Products
Life Sciences & Healthcare Regulatory counsel Bryant Godfrey was quoted in a recent POLITICO Pro article, "CBD Industry Eager for FDA Guidance." The article notes the CBD industry's requests for clarity about FDA regulations for labeling standards, testing requirements, and contamination rules for CBD products. Industry observers in the article discuss potential nuances to the FDA's guidance.
» Read the full article (subscription required).